213 related articles for article (PubMed ID: 30674867)
1. Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma.
Mohanty S; Yerneni K; Theruvath JL; Graef CM; Nejadnik H; Lenkov O; Pisani L; Rosenberg J; Mitra S; Cordero AS; Cheshier S; Daldrup-Link HE
Cell Death Dis; 2019 Jan; 10(2):36. PubMed ID: 30674867
[TBL] [Abstract][Full Text] [Related]
2. Novel Clinically Translatable Iron Oxide Nanoparticle for Monitoring Anti-CD47 Cancer Immunotherapy.
Roudi R; Pisani L; Pisani F; Kiru L; Daldrup-Link HE
Invest Radiol; 2024 May; 59(5):391-403. PubMed ID: 37812494
[TBL] [Abstract][Full Text] [Related]
3. Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on.
Mohanty S; Aghighi M; Yerneni K; Theruvath JL; Daldrup-Link HE
Mol Oncol; 2019 Oct; 13(10):2049-2061. PubMed ID: 31376208
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation.
Aghighi M; Theruvath AJ; Pareek A; Pisani LL; Alford R; Muehe AM; Sethi TK; Holdsworth SJ; Hazard FK; Gratzinger D; Luna-Fineman S; Advani R; Spunt SL; Daldrup-Link HE
Clin Cancer Res; 2018 Sep; 24(17):4110-4118. PubMed ID: 29764855
[No Abstract] [Full Text] [Related]
5. Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.
Zhu H; Leiss L; Yang N; Rygh CB; Mitra SS; Cheshier SH; Weissman IL; Huang B; Miletic H; Bjerkvig R; Enger PØ; Li X; Wang J
Oncotarget; 2017 Feb; 8(7):12145-12157. PubMed ID: 28076333
[TBL] [Abstract][Full Text] [Related]
6. Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer.
Ng TSC; Gunda V; Li R; Prytyskach M; Iwamoto Y; Kohler RH; Parangi S; Weissleder R; Miller MA
Radiology; 2021 Jan; 298(1):123-132. PubMed ID: 33107799
[TBL] [Abstract][Full Text] [Related]
7. Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
[TBL] [Abstract][Full Text] [Related]
8. MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.
Daldrup-Link HE; Golovko D; Ruffell B; Denardo DG; Castaneda R; Ansari C; Rao J; Tikhomirov GA; Wendland MF; Corot C; Coussens LM
Clin Cancer Res; 2011 Sep; 17(17):5695-704. PubMed ID: 21791632
[TBL] [Abstract][Full Text] [Related]
9. CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis.
Liu R; Wei H; Gao P; Yu H; Wang K; Fu Z; Ju B; Zhao M; Dong S; Li Z; He Y; Huang Y; Yao Z
Oncotarget; 2017 Jun; 8(24):39021-39032. PubMed ID: 28380460
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.
Muehe AM; Siedek F; Theruvath AJ; Seekins J; Spunt SL; Pribnow A; Hazard FK; Liang T; Daldrup-Link H
Theranostics; 2020; 10(8):3612-3621. PubMed ID: 32206111
[TBL] [Abstract][Full Text] [Related]
11. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
13. Magnetic resonance imaging of stem cell-macrophage interactions with ferumoxytol and ferumoxytol-derived nanoparticles.
Nejadnik H; Tseng J; Daldrup-Link H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1552. PubMed ID: 30734542
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Ferumoxytol as a Breast Cancer-Associated Macrophage Tracer with Five-Dimensional Quantitative [Fe]MRI of SPION Dynamics.
Sillerud LO; Neuwelt AJ; Staquicini FI; Arap W; Pasqualini R
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359704
[TBL] [Abstract][Full Text] [Related]
15. Ferumoxytol magnetic resonance imaging detects joint and pleural infiltration of bone sarcomas in pediatric and young adult patients.
Theruvath AJ; Rashidi A; Nyalakonda RR; Avedian RS; Steffner RJ; Spunt SL; Daldrup-Link HE
Pediatr Radiol; 2021 Dec; 51(13):2521-2529. PubMed ID: 34410452
[TBL] [Abstract][Full Text] [Related]
16. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.
Sakakura K; Takahashi H; Kaira K; Toyoda M; Murata T; Ohnishi H; Oyama T; Chikamatsu K
Lab Invest; 2016 Sep; 96(9):994-1003. PubMed ID: 27322955
[TBL] [Abstract][Full Text] [Related]
17. A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration.
Gong M; Huang Y; Feng H; Lin J; Huang A; Hu J; Tang Q; Zhu X; Han S; Lu J; Wang J
J Control Release; 2023 Mar; 355():68-84. PubMed ID: 36682726
[TBL] [Abstract][Full Text] [Related]
18. CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes.
Kosaka A; Ishibashi K; Nagato T; Kitamura H; Fujiwara Y; Yasuda S; Nagata M; Harabuchi S; Hayashi R; Yajima Y; Ohara K; Kumai T; Aoki N; Komohara Y; Oikawa K; Harabuchi Y; Kitada M; Kobayashi H; Ohkuri T
J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34559187
[TBL] [Abstract][Full Text] [Related]
19. PARP inhibition synergizes with CD47 blockade to promote phagocytosis by tumor-associated macrophages in homologous recombination-proficient tumors.
Liu Y; Xue R; Duan X; Shang X; Wang M; Wang F; Zhu L; Zhang L; Ge X; Zhao X; Guo H; Wang Z; Zhang L; Gao X; Shen A; Sheng Y; Qin Z
Life Sci; 2023 Aug; 326():121790. PubMed ID: 37211345
[TBL] [Abstract][Full Text] [Related]
20. Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages.
Sakamoto M; Murata Y; Tanaka D; Kakuchi Y; Okamoto T; Hazama D; Saito Y; Kotani T; Ohnishi H; Miyasaka M; Fujisawa M; Matozaki T
Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34949714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
